People · Operator
Named in public records as an officer, director or promoter · active 2014–2018 · Other Technology, Pharmaceuticals, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Surna Inc. | — | Other Technology | Seed | $7.4M | $56.5M | 2017 |
| Supreme Pharmaceuticals Inc. | — | Pharmaceuticals | Seed | $2.9M | $14.1M | 2014 |
| Ravenquest Biomed Inc. | — | Other | Pre-Seed | $2.1M | $7.3M | 2017 |
Chris Bechtel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chris Bechtel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marla Ritchie | 1 | 8 |
| Anton J. Drescher | 1 | 6 |
| David Cross | 1 | 6 |
| John Fowler | 1 | 5 |
| Paul Kelly | 1 | 5 |
| Henk Van Alphen | 1 | 5 |
| Anton Drescher | 1 | 4 |
| Scott Walters | 1 | 3 |
| GEORGE TSAFALAS | 1 | 3 |
| DAVID STADNYK | 1 | 3 |
| David J. Cross | 1 | 2 |
| Tatiana Kovaleva | 1 | 2 |
| CHUCK RIFICI | 1 | 2 |
| Brian Knaley | 1 | 2 |
| Jorge Bonet | 1 | 1 |
| Navdeep Dhaliwal | 1 | 1 |
| Michael La Brier | 1 | 1 |
| Allan Levien | 1 | 1 |
| Cailin Gehlsen | 1 | 1 |
| Christopher Bechtel | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.